1. Conze D, Brenner C, Kruger CL, et al. (2019). Safety and metabolism of long-term administration of nicotinamide riboside in healthy adults. Scientific Reports, 9, 12841.
2. Martens CR, Denman BA, Mazzo MR, et al. (2018). Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults. Nature Communications, 9, 1286.
3. Trammell SAJ. Schmidt MS, Weidemann BJ, et al. (2016). Nicotinamide riboside is uniquely and orally bioavailable in mice and humans. Nature Communications, 7, 12948.
4. Ying W. (2008). NAD+ and NADH in Cellular Functions and Cell Death. Frontiers in Bioscience, 13, 3126-3148.
5. Yoshino J, Mills KF, Yoon MJ, et al. (2011). Nicotinamide mononucleotide, a key NAD + intermediate. treats the pathophysiology of diet- and age-induced diabetes in mice. Cell Metabolism, 14(4), 528-536.